Related Experiment Video
Updated: Aug 25, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Current and Emerging Therapies in Pediatric Atopic Dermatitis
1University of Minnesota Medical School, Minneapolis, MN, USA.
Atopic dermatitis (AD) is a common inflammatory skin condition in children. This article reviews current, emerging, and alternative therapies for managing pediatric AD, considering its diverse symptoms and severity.
Area of Science:
- Pediatric Dermatology
- Inflammatory Skin Diseases
- Therapeutic Strategies
Background:
- Atopic dermatitis (AD) is the most prevalent inflammatory skin condition in pediatric populations.
- AD presents as a heterogeneous disorder with varied manifestations and symptom severity, ranging from mild to severe.
- Effective management of pediatric AD necessitates a broad range of therapeutic interventions.
Purpose of the Study:
- To provide a comprehensive overview of therapeutic options for pediatric atopic dermatitis.
- To discuss current, emerging, and alternative treatment strategies for managing AD in children.
- To address the spectrum of therapies applicable to the diverse clinical presentations of pediatric AD.
Main Methods:
- Literature review of existing and novel therapeutic approaches for atopic dermatitis.
- Analysis of prescription and nonprescription treatments relevant to the pediatric population.
- Inclusion of alternative and complementary therapies in the management of pediatric AD.
Main Results:
- A wide array of treatment modalities are available for pediatric atopic dermatitis.
- Current therapies encompass various classes of prescription and nonprescription agents.
- Emerging and alternative options offer additional avenues for managing this condition.
Conclusions:
- A multifaceted therapeutic approach is essential for effectively managing pediatric atopic dermatitis.
- The selection of therapy should be tailored to the individual child's disease severity and specific symptoms.
- Continued research into emerging and alternative therapies holds promise for improved outcomes in pediatric AD management.
More Related Videos
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Clinical Applications of Epidermal Stem Cells
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: